%0 Journal Article
%T Special considerations and pitfalls for intracerebral bleeding followed COVID-19 case treated by ECMO.
%A Amer WO
%A El Gharieb HA
%A Ahmed Z
%A Ibrahim H
%A Alanazi A
%A Meshref M
%J Brain Hemorrhages
%V 0
%N 0
%D 2023 Jun 10
%M 37359506
暂无%R 10.1016/j.hest.2023.06.001
%X COVID-19, or coronavirus infection, is an acute respiratory illness caused by the corona virus that can develop into a life-threatening form of ARDS. Extracorporeal membrane oxygenation (ECMO) is a highly effective treatment for life-threatening instances. One of the many complications associated with ECMO was bleeding. COVID patients are at risk for intracerebral bleeding due to several factors, including the drug's action on ACE2 receptors, leading to hypertension, as well as hypercoagulability, dysregulated immune response, DIC, and the use of anticoagulants.